Derivation and maturation of synthetic and contractile vascular smooth muscle cells from human pluripotent stem cells

Abstract

We control hPSC differentiation into synthetic or contractile phenotypes by using appropriate concentrations of relevant factors. Deriving Con-vSMCs from an integration-free hiPSC line may prove useful for regenerative therapy involving blood vessel differentiation and stabilization.